Ernest Pharmaceuticals
PrivateLast Round
Grant
Mar 7, 2024
Total Funding Raised
$1.55M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Ernest Pharmaceuticals is a biotechnology company that develops bacterial therapeutics for the treatment of solid tumors through intracellular macromolecule delivery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ernest Pharmaceuticals Comparables
Compare Ernest Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Laguna Bio | 82% | |
| Neobe Therapeutics | 82% | |
| Actym Therapeutics | 81% |
Ernest Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 7, 2024 | ||||
| Accelerator | Mar 16, 2022 | ||||
| Grant | Jan 15, 2021 | ||||
| Grant | Sep 15, 2020 | ||||
| Grant | Sep 13, 2019 | ||||
Grant | Sep 9, 2018 |
Ernest Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| The Termeer Institute | Accelerator |
| Massachusetts Life Sciences Center | Grant |
| National Institutes of Health (NIH) | Grant |
| Lever | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 2295% MoM, reaching 2.1K.
- Mar 1, 2026
Monthly visitors grew 641% MoM, from 200 to 1.5K.
Ernest Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ernest Pharmaceuticals's valuation, stock price, and market status.
Is Ernest Pharmaceuticals a public or private company?
Ernest Pharmaceuticals is a private company.
What is the current stock price of Ernest Pharmaceuticals?
Ernest Pharmaceuticals is a private company with no public stock price. Caplight tracks Ernest Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Ernest Pharmaceuticals worth (valuation)?
Valuation information for Ernest Pharmaceuticals is not publicly available.
Can I buy Ernest Pharmaceuticals stock?
Ernest Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ernest Pharmaceuticals's last funding round?
Ernest Pharmaceuticals's most recent funding round was Grant on March 7, 2024.
Who are the main investors in Ernest Pharmaceuticals?
Key investors in Ernest Pharmaceuticals include National Cancer Institute, The Termeer Institute, Massachusetts Life Sciences Center, National Institutes of Health (NIH), Lever.
Will Ernest Pharmaceuticals IPO soon?
No public IPO plans have been announced for Ernest Pharmaceuticals.
How can I track Ernest Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ernest Pharmaceuticals's secondary market activity and sign up for updates.